News Overview | chemanager-online.com - Chemistry and Life Science

Nov. 11, 2019
News & OpinionsHeadlines
Solvay’s new Strategy Sets Growth Goals
Belgian chemical producer Solvay has launched a new operating model called Solvay ONE to pursue its G.R.O.W forward strategy. CEO Ilham Kadri said the goal is to unleash the group’s full potential through a “disciplined and ...
Nov. 11, 2019
News & OpinionsHeadlines
Trinseo Retains Stade PC Plant
Following a strategic review of its polycarbonate (PC) activities announced in May this year, US plastics and rubber producer Trinseo has decided to keep its PC manufacturing plant in Stade, Germany. ...
Nov. 11, 2019
News & OpinionsHeadlines
Have EU’s new TiO2 Classification Plans Hit a Snag?
Plans by the European Commission to classify titanium dioxide (TiO2) in inhalable powder form as a category 2 suspected human carcinogen, adopted in mid-September, may have hit a snag. ...
Nov. 08, 2019
News & OpinionsHeadlines
MonoSol Hikes Films Capacity in Poland, USA
MonoSol, a division of Japanese specialty chemical company Kuraray, is planning to expand capacity for water-soluble and biodegradable films in Poland and the US to meet rapidly rising demand.
Nov. 08, 2019
News & OpinionsHeadlines
Adama in JV with China’s Huifeng Prior to Takeover
Following the signing of a Memorandum of Understanding in January, Adama and China’s Jiangsu Huifeng Bio Agriculture have now entered into a joint venture in advance of a larger transaction in which the Israeli agrochemicals group ...
Nov. 08, 2019
News & OpinionsHeadlines
Stephen Hahn Tapped to Head FDA
US president Donald Trump has nominated Stephen Hahn as the next commissioner of the Food and Drug Administration (FDA) which will follow Congressional approval. Hahn, currently MD Anderson Cancer Center’s chief medical executive, ...
Nov. 07, 2019
News & OpinionsHeadlines
Kraton Sells Cariflex Unit to Daelim
US specialty chemical company Kraton has agreed to sell its Cariflex business to South Korean petrochemical group Daelim Industrial for $530 million. ...
Nov. 07, 2019
News & OpinionsHeadlines
Sanofi Pays $315 Million to End Lemtrada Claims
French drugmaker Sanofi has paid $315 million to investors to settle claims it dragged its feet on advancing the development of multiple sclerosis drug Lemtrada, which it acquired with the buyout of Genzyme in 2011. ...

…5 6 789 10 11 12…

Register now!

The latest information directly via newsletter.

GIT Verlag